,date,symbol,fillingDate,acceptedDate,period,netIncome,depreciationAndAmortization,deferredIncomeTax,stockBasedCompensation,changeInWorkingCapital,accountsReceivables,inventory,accountsPayables,otherWorkingCapital,otherNonCashItems,netCashProvidedByOperatingActivities,investmentsInPropertyPlantAndEquipment,acquisitionsNet,purchasesOfInvestments,salesMaturitiesOfInvestments,otherInvestingActivites,netCashUsedForInvestingActivites,debtRepayment,commonStockIssued,commonStockRepurchased,dividendsPaid,otherFinancingActivites,netCashUsedProvidedByFinancingActivities,effectOfForexChangesOnCash,netChangeInCash,cashAtEndOfPeriod,cashAtBeginningOfPeriod,operatingCashFlow,capitalExpenditure,freeCashFlow,link,finalLink
0,2019-12-31,BVXV,,,FY,-109194000,1645000.0,0.0,3684000.0,11027000,0.0,0.0,-3661000.0,14252000,15902000,-77058000,0.0,0.0,0.0,0.0,230000.0,0.0,-581000.0,70270000,0.0,0.0,0.0,0.0,0.0,0.0,72467000,75883000,-77058000,-7429000.0,-84487000,,
0,2018-12-31,BVXV,2019-04-30,,FY,-87727000,260000.0,0.0,260000.0,31419000,0.0,0.0,14500000,13545000,-1456000.0,-57193000,0.0,0.0,0.0,0.0,140000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,75883000,71382000,-57193000,-23731000,-80924000,https://www.sec.gov/Archives/edgar/data/1611747/000121390019007348/f20f2018_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390019007348/f20f2018_biondvaxpharma.htm
0,2017-12-31,BVXV,2018-04-30,,FY,-34551000,440000.0,0.0,519000.0,2400000.0,0.0,0.0,5537000.0,0.0,21195000,-10050000,0.0,0.0,0.0,4067000.0,7200000.0,0.0,0.0,55692000,0.0,0.0,0.0,0.0,0.0,0.0,71382000,15705000,-10050000,-4508000.0,-14558000,https://www.sec.gov/Archives/edgar/data/1611747/000121390018005179/f20f2017_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390018005179/f20f2017_biondvaxpharma.htm
0,2016-12-31,BVXV,2017-04-28,,FY,-9184000.0,621000.0,0.0,1261000.0,323000.0,0.0,0.0,-238000.0,0.0,-2716000.0,-9653000.0,0.0,0.0,0.0,0.0,-7793000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15705000,33470000,-9653000.0,-20000.0,-9673000.0,https://www.sec.gov/Archives/edgar/data/1611747/000121390017004338/f20f2016_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390017004338/f20f2016_biondvaxpharma.htm
0,2015-12-31,BVXV,2016-04-27,,FY,-10199000,628000.0,0.0,745000.0,-339000.0,0.0,0.0,415000.0,-20000.0,-1104000.0,-10267000,0.0,0.0,0.0,0.0,-9000.0,0.0,0.0,27323000,0.0,0.0,0.0,0.0,0.0,0.0,33470000,9612000.0,-10267000,-34000.0,-10301000,https://www.sec.gov/Archives/edgar/data/1611747/000121390016012814/f20f2015_biondvaxpharma.htm,https://www.sec.gov/Archives/edgar/data/1611747/000121390016012814/f20f2015_biondvaxpharma.htm
0,2014-12-31,BVXV,,,FY,-7764000.0,677000.0,0.0,363000.0,-529000.0,0.0,0.0,132000.0,0.0,-378000.0,-7572000.0,0.0,0.0,0.0,0.0,-150000.0,0.0,0.0,0.0,0.0,0.0,-788000.0,0.0,0.0,0.0,9612000.0,17863000,-7572000.0,-30000.0,-7602000.0,,
